Centiva Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Centiva Capital’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,474	Closed	-$367K	–	2289
2024 Q1	$367K	Buy	+8,474	New	+$404K	0.02%	1145
2023 Q4	–	Sell	-13,307	Closed	-$604K	–	2014
2023 Q3	$604K	Buy	+13,307	New	+$549K	0.03%	870
2022 Q3	–	Hold	0	–	–	–	1671
2022 Q2	–	Hold	0	–	–	–	1847
2020 Q1	–	Sell	-28,932	Closed	-$1.75M	–	773
2019 Q4	$1.75M	Buy	28,932 +21,596	+294%	+$1.29M	0.3%	215
2019 Q3	$439K	Buy	+7,336	New	+$478K	0.09%	361

Other funds holding IONS

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return